Jump to navigation
The latest clinical and political news for Australian Rheumatologists
A long-term patient needs hospital care. But was her management evidence-based?
Evidence is being ignored despite concern over harms and cost, researchers say.
Febuxostat linked to increased risk of cardiac and all-cause mortality.
Stepwise febuxostat | Assessing patient fears | Resistance exercise in RA
Study evaluates risks lor low bone mineral density.
But there’s a question mark over skin cancers.
A physician-driven initiative.
Five times as many women as men are affected.
The latest on lupus.
The risk is similar to that conferred by having diabetes, research shows.
Australian research shows mannose binding lectin deficiency raises risk.
Among other benefits, patients are more satisfied.
Fears about teratogenicity appear unfounded.
It appears to have metabolic benefits.
Two studies suggest a connection between smoking and autoimmunity
"Going back to having to write notes on paper ... was a set-back"
PBAC and etanercept; uric acid and dementia; stopping biologics in JIA.
A Dutch trial shows good clinical and radiological outcomes.
Sjögren’s diagnosis may bring relief: study
Reducing high exposure to the drug does not worsen disease
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.